In a new blow to Boston Scientific, the FDA has warned the medical device manufacturer that it committed "serious violations" following the deaths of patients involved in a clinical trial.
The regulator claims the company failed to determine whether two of five deaths that occurred in patients implanted with a stent graft were caused by the device. It also allegedly failed to report the adverse events and did not request follow-up information from the trial sites following the deaths.
More
No comments:
Post a Comment